Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 EUR | -0.33% | -4.10% | -34.90% |
Mar. 18 | Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development | MT |
Mar. 18 | Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG | CI |
Sales 2024 * | 3M 3.22M | Sales 2025 * | 3M 3.22M | Capitalization | 98.08M 105M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 32.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 32.7 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 75 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.77% |
Latest transcript on Biotalys NV
1 day | -0.66% | ||
1 week | -4.42% | ||
Current month | -1.62% | ||
1 month | -1.62% | ||
3 months | -31.45% | ||
6 months | -3.19% | ||
Current year | -35.12% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin R. Helash
CEO | Chief Executive Officer | 59 | Nov. 30 |
Douglas Minder
DFI | Director of Finance/CFO | - | 20-12-31 |
Carlo Boutton
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 12-12-31 | |
Simon Moroney
CHM | Chairman | 65 | 21-03-31 |
Johan Cardoen
BRD | Director/Board Member | 65 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.04 | -0.33% | 17 467 |
24-04-25 | 3.05 | 0.00% | 6,295 |
24-04-24 | 3.05 | -0.33% | 6,939 |
24-04-23 | 3.06 | -1.92% | 17,600 |
24-04-22 | 3.12 | -1.58% | 12,159 |
Real-time Euronext Bruxelles, April 26, 2024 at 08:28 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.12% | 105M | |
+0.10% | 7.35B | |
+7.18% | 3.15B | |
+9.03% | 859M | |
-4.31% | 355M | |
+18.64% | 308M |
- Stock Market
- Equities
- BTLS Stock